.
New Delhi, April 26 (MondayMirror.com) The Drugs Controller General of India (DCGI) on Tuesday approved the restricted emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for children between the age of 6-12 years, sources said.
The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event with due analysis every 15 days for the first two months and monthly thereafter upto 5 months, said the source familiar with the development.
This development comes after the Subject Expert Committee (SEC) discussed recommendations for the restricted emergency use of Covaxin in children aged between 2-12 years.
However, the SEC, after a meeting on Thursday, had recommended restricted emergency use of Biological E’s Covid-19 vaccine, Corbevax, in children aged 5-12 years.
Source: IANS
Actress Ridhi Dogra, who is all set to step into “The 50”, says that she…
Actress Raveena Tandon is the latest Bollywood celeb to join the ongoing "2026 is the…
In recent days, a series of videos showing people bypassing subway fare gates in New…
and Bipasha Basu were hit by a massive wave of nostalgia as their song…
Actress Khushi Kapoor is clearly prioritising fitness and self-care as she steps into what she…
Tollywood star Allu Arjun was in Tokyo, Japan, to promote his blockbuster hit "Pushpa 2:…